Literature DB >> 11295048

Polymorphism and allelic loss at the AS3 locus on 13q12-13 in esophageal squamous cell carcinoma.

H Harada1, N Uchida, Y Shimada, H Kumimoto, M Shinoda, M Imamura, K Ishizaki.   

Abstract

Our previous studies of esophageal squamous cell carcinoma (ESC) revealed that frequent loss of heterozygosity (LOH) on 13q12-13 was associated with lymph node metastasis. These results suggest that 13q12-13 may harbor a tumor suppressor gene which regulates lymph node metastasis. Recently, a new tumor suppressor candidate, AS3, was identified in this region. We therefore examined AS3 alterations by PCR-SSCP and RT-PCR. Although polymorphisms were found in exon 10 and introns 21, 23, 25 and 29, a possible tumor specific mutation in exon 6 was identified in only one of 31 ESC-derived cell lines, indicating that the remaining allele of AS3 was rarely inactivated by mutational events. Interestingly, ESC patients with rare alleles frequently exhibited lymph node metastasis. These results suggest that polymorphic variation and LOH at the AS3 locus might be associated with lymph node involvement in ESC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295048     DOI: 10.3892/ijo.18.5.1003

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.

Authors:  P Geck; C Sonnenschein; A M Soto
Journal:  Am J Hum Genet       Date:  2001-08       Impact factor: 11.025

2.  APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

Authors:  Maricel Maffini; Viktoria Denes; Carlos Sonnenschein; Ana Soto; Peter Geck
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-12       Impact factor: 4.292

3.  Downregulation of APRIN expression increases cancer cell proliferation via an interleukin-6/STAT3/cyclin D axis.

Authors:  Min-Shik Sohn; Miae Kang; Seong-Man Kang; Sangwoo Bae
Journal:  Oncol Lett       Date:  2020-11-18       Impact factor: 2.967

4.  APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.

Authors:  Rachel Brough; Ilirjana Bajrami; Radost Vatcheva; Rachael Natrajan; Jorge S Reis-Filho; Christopher J Lord; Alan Ashworth
Journal:  EMBO J       Date:  2012-01-31       Impact factor: 11.598

Review 5.  PDS5A and PDS5B in Cohesin Function and Human Disease.

Authors:  Nenggang Zhang; Luiza E Coutinho; Debananda Pati
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.